ADVERTISEMENT
lower prices drug companies charge overseas compared with the U.S. and has sought to address that gap through pressure including tariffs and “most favored nation” pricing agreements, where drugmakers agree not to charge more for certain products than what patients pay in other high-income countries.
ADVERTISEMENT